IP Verse

Schlich patent opposition analysis

The comprehensive analysis of Schlich opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Schlich

Stay updated with the latest patent oppositions filed by Schlich

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3553174
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEJan 30, 2026SCHLICH
EP3709026
Instrument For Analyzing Biological Samples And ReagentsLGC GENOMICSApr 17, 2025CR BIOSCIENCE
EP3501610
Housing Of A Closed Circuit Breathing ApparatusDRGER SAFETYOct 31, 2024SCHLICH
EP4028021
Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding CompositionsNUVAMIDMay 30, 2024SCHLICH
EP4084799
Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding CompositionsNUVAMIDMay 30, 2024SCHLICH
EP4196127
Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell DisorderNUVAMIDMay 30, 2024SCHLICH
EP3578175
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023GLENMARK PHARMACEUTICALS EUROPE
EP2653873
Compositions And Uses For Treating Multiple SclerosisBIOGEN MAApr 19, 2023GLENMARK PHARMACEUTICALS EUROPE
EP3733847
Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATEDMar 1, 2023SCHLICH
EP3090023
Improved Phtalate-Free Polyvinyl Chloride Plastisol CompositionsTARKETT GDLJan 25, 2023SCHLICH

Top clients of Schlich

Top companies who are the clients of Schlich

CompanyTotal
SCHLICH43
GLENMARK PHARMACEUTICALS EUROPE16
IMUTEX2
JOSAFATSSON2
CR BIOSCIENCE1